绥美凯多少钱一盒？

It is a compound preparation. Each tablet contains 50 mg of dolutegravir sodium (calculated as dolutegravir), 600 mg of abacavir sulfate (calculated as abacavir) and 300 mg of lamivudine. It is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV).

The recommended dosage of SuimeiKai is one tablet, once daily. Adults or adolescents whose weight is less than 40kg should not be given Trimax, because Trimax is a fixed-dose tablet and the dose cannot be reduced. Reducing the dose without authorization may result in the inefficiency of the drug. Because ingredients in Trimax may cause hypersensitivity reactions, patients should be screened for the HLA-B*5701 allele before starting treatment with abacavir-containing products, regardless of race. 

Suimeikai is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China. It was approved for marketing in January 2018. It has the characteristics of high efficacy, good tolerability, high resistance barrier and few drug interactions. 

After Suimeikai was launched in my country, its price has always been an aspect that everyone is more concerned about. The domestic price of Suimeikan is 2880$/month. If long-term medication is required, the financial burden will be relatively heavy for patients.

In addition to domestic original drugs, Suimeikai, which is currently on the market in India, is more popular among domestic patients. Its specification is 30 tablets/box and the price is about RMB 1,000. The price is far lower than that in China. If patients need to purchase it, they can consult the medical companion travel service for specific information.

Regardless of which version is purchased, use is contraindicated in patients with known hypersensitivity to dolutegravir, abacavir, and lamivudine or any excipients. Furthermore, the combined use of Trimax with dofetilide and pixicanide is prohibited. To ensure life safety, patients should not change their medications at will. If any abnormality occurs, they need to contact their doctor in time.